Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [(89)Zr]Zr-DFO-PEG(5)-Tz

[Image: see text] The recent advances in the production of engineered antibodies have facilitated the development and application of tailored, target-specific antibodies. Positron emission tomography (PET) of these antibody-based drug candidates can help to better understand their in vivo behavior....

Descripción completa

Detalles Bibliográficos
Autores principales: Lumen, Dave, Vugts, Danielle, Chomet, Marion, Imlimthan, Surachet, Sarparanta, Mirkka, Vos, Ricardo, Schreurs, Maxime, Verlaan, Mariska, Lang, Pauline A., Hippeläinen, Eero, Beaino, Wissam, Windhorst, Albert D., Airaksinen, Anu J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121349/
https://www.ncbi.nlm.nih.gov/pubmed/35442642
http://dx.doi.org/10.1021/acs.bioconjchem.2c00164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121349/
https://www.ncbi.nlm.nih.gov/pubmed/35442642
http://dx.doi.org/10.1021/acs.bioconjchem.2c00164

Ejemplares similares